DELUCCIA ROBERT J - 23 Feb 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role: Director, 10%+ Owner
Signature: /s/ Kostantinos Skordalos, Power of Attorney For: Robert J. DeLuccia
Issuer symbol: ACXP
Transactions as of: 23 Feb 2024
Net transactions value: $0
Form type: 4
Filing time: 03 Apr 2024, 21:55:50 UTC
Previous filing: 24 Feb 2023
Next filing: 08 Jan 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACXP	Stock Option	Award	$0	+250,000		$0.000000	250,000	23 Feb 2024	Common Stock	250,000	$3.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 23, 2024 (the "Grant Date"), the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.